Send mail to Author

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  _    _    _    _    _    _    _    __   __    _____   
 | \| || | || | || | \  / || | || | ||  \ \\/ //  |  ___|| 
 |  ' || | || | || |  \/  || | || | ||   \   //   | ||__   
 | .  || | \\_/ || | .  . || | \\_/ ||   / . \\   | ||__   
 |_|\_||  \____//  |_|\/|_||  \____//   /_//\_\\  |_____|| 
 `-` -`    `---`   `-`  `-`    `---`    `-`  --`  `-----`
 


Back to frontdoor view

OPUS4 Logo